Results 171 to 180 of about 271,461 (267)

Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium. [PDF]

Liver Int
Buchardt L, Thi VLD, Johne R, Ziersch M, Harms D, Hofmann J, Dinkelborg K, Klöhn M, Choi M, Kurreck J, Wedemeyer H, Todt D.   +11 more
europepmc   +1 more source

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source

Long-term protection from naturally acquired immunity against hepatitis E virus reinfection. [PDF]

Nat Commun
Liu X, Zang X, Zhu K, Huang X, Hu X, Bi Z, Chen Q, Jiang H, Wang Y, Yang C, Liu D, Zhu W, Zheng Z, Su Y, Wu T, Huang S, Zhuang C, Zhang J, Xia N.   +18 more
europepmc   +1 more source

Presencia de anticuerpos anti virus hepatitis E en pacientes con infección aguda por virus hepatitis A [PDF]

Natalia Covarrubías, Julio Miranda, Caterina Chesta, Mauricio Venegas, Carmen Hurtado   +4 more
openalex   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

Developmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff, Sandra Schrenk, Kara Soroko, Chhiring Sherpa, Ashok Arasu, Damien Reynaud, Elisa Boscolo   +6 more
wiley   +1 more source

Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection. [PDF]

Liver Int
Schemmerer M, Pflüger LS, Schneider T, Lu J, Kienle K, Meyer-Schlinkmann KM, Mühlbacher A, Polz J, Schennach H, Xie Q, Voitenleitner C, Wenzel J, Lütgehetmann M.   +12 more
europepmc   +1 more source

Hepatitis E Virus A Potential Threat to Pregnancy

, 2014
Rosy Sultana
openalex   +2 more sources

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Acute hepatitis E virus infection as a trigger for postinfectious IgA nephropathy: A rare case report. [PDF]

Medicine (Baltimore)
Khan M, Khan Z, Altaf A, Bibi S, Batool I, Naamani AER, Fakih N.   +6 more
europepmc   +1 more source

Screening for Hepatitis E virus (HEV) in slaughtered pig for meat in Uyo using both serological and molecular methods and assessing their public health appraisal

M.O. Irabor, Anthony A. Adegoke, C.U. Inyang, Opeyemi K. Fatunla, Moses E. Ekpenyong   +4 more
openalex   +2 more sources